Section 3 - Study Organization (Phase 3 - 12/2010)
Section 3 - Page 7
3.3.2.
Coordinating Center
Wake Forest University School of Medicine
Winston-Salem, NC
3.3.3.
Federal Sponsors
Centers for Disease Control and Prevention, Division
of Diabetes Translation,
Atlanta, GA
National Institutes of Health, National Institute of Diabetes
and Digestive and Kidney
Diseases,
Bethesda, MD
3.3.4.
Central Laboratory
Northwest Lipid Metabolism and Diabetes
Research Laboratories
University of Washington
Seattle, WA
SEARCH Phase 3 Protocol - Section 4A
Registry
Study
Study Objectives & Background and Significance
Table
of Contents
4.
Dostları ilə paylaş: 
